1. Home
  2. TVRD vs WOLF Comparison

TVRD vs WOLF Comparison

Compare TVRD & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • WOLF
  • Stock Information
  • Founded
  • TVRD 2017
  • WOLF 1987
  • Country
  • TVRD United States
  • WOLF United States
  • Employees
  • TVRD N/A
  • WOLF N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • WOLF Semiconductors
  • Sector
  • TVRD Health Care
  • WOLF Technology
  • Exchange
  • TVRD Nasdaq
  • WOLF Nasdaq
  • Market Cap
  • TVRD 246.5M
  • WOLF 200.8M
  • IPO Year
  • TVRD N/A
  • WOLF 1993
  • Fundamental
  • Price
  • TVRD $29.92
  • WOLF $1.24
  • Analyst Decision
  • TVRD Strong Buy
  • WOLF Hold
  • Analyst Count
  • TVRD 5
  • WOLF 10
  • Target Price
  • TVRD $59.20
  • WOLF $8.39
  • AVG Volume (30 Days)
  • TVRD 23.2K
  • WOLF 8.0M
  • Earning Date
  • TVRD 08-14-2025
  • WOLF 08-25-2025
  • Dividend Yield
  • TVRD N/A
  • WOLF N/A
  • EPS Growth
  • TVRD N/A
  • WOLF N/A
  • EPS
  • TVRD N/A
  • WOLF N/A
  • Revenue
  • TVRD N/A
  • WOLF $757,600,000.00
  • Revenue This Year
  • TVRD N/A
  • WOLF $15.82
  • Revenue Next Year
  • TVRD N/A
  • WOLF $16.47
  • P/E Ratio
  • TVRD N/A
  • WOLF N/A
  • Revenue Growth
  • TVRD N/A
  • WOLF N/A
  • 52 Week Low
  • TVRD $8.13
  • WOLF $0.39
  • 52 Week High
  • TVRD $34.31
  • WOLF $3.33
  • Technical
  • Relative Strength Index (RSI)
  • TVRD 65.43
  • WOLF 41.71
  • Support Level
  • TVRD $22.91
  • WOLF $1.17
  • Resistance Level
  • TVRD $31.54
  • WOLF $1.46
  • Average True Range (ATR)
  • TVRD 1.65
  • WOLF 0.10
  • MACD
  • TVRD 0.61
  • WOLF -0.02
  • Stochastic Oscillator
  • TVRD 81.28
  • WOLF 24.14

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

Share on Social Networks: